Research

And Grants

Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.

Submit Grant Application

Home > Research and Grants

The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.

The Cure Starts Now has funded $25,466,182 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 170 grants at over 100 hospitals in 29 countries.




Johns Hopkins Hospital – $100,000

Amount
$100,000.00
Date
December 2024

Leveraging Epigenetic Alterations for Therapy of Diffuse Midline Glioma

Grant Information

CONNECT Consortium (TarGeT 2025) - $32,230 USD / $50,000 AUD

Amount
$32,230.00
Date
December 2024

TarGeT 2025

Grant Information

CONNECT Consortium (TarGeT 2026) - $32,230 USD / $50,000 AUD

Amount
$32,230.00
Date
December 2024

TarGeT 2026

Grant Information

CONNECT Consortium (TarGeT 2027) - $6,445 USD / $10,000 AUD

Amount
$6,445.00
Date
December 2024

TarGeT 2027

Grant Information

Children’s Hospital of Philadelphia – $100,000

Amount
$100,000.00
Date
December 2024

Cytokine Signaling in Diffuse Midline Glioma to Enhance GD2-Directed CAR T Cell Trafficking

Grant Information

UNC Eshelman School of Pharmacy – $50,000

Amount
$50,000.00
Date
December 2024

Leveraging Open Science and Collaboration to Identify Clinical Quality ALK2 Inhibitors for DIPG

Grant Information

Murdoch Children's Research Institute – $100,000 USD / $156,914 AUD

Amount
$100,000.00
Date
December 2024

Harnessing Developmental Neurobiology to Reprogram the Cell of Origin of Diffuse Midline Gliomas

Grant Information

Children’s Cancer Institute – $70,400 USD / $110,467 AUD

Amount
$70,400.00
Date
December 2024

A Novel Formulation to Allow the Simultaneous Targeting of MYC Expression and Copper Chelation to Treat DIPG Tumor and Overcome Multidrug Resistance

Grant Information

The Institute for Medical Research Israel-Canada – $40,000 USD / 143,580 INS

Amount
$40,000.00
Date
December 2024

CXCR1/2 Signaling Pathway: A Role in the Invasive Mechanism of DIPG

Grant Information

Children's Healthcare of Atlanta – $100,000

Amount
$100,000.00
Date
November 2024

Radiation Resistance in Medulloblastoma

Grant Information

University of Texas Health Science Center at San Antonio – $100,000

Amount
$100,000.00
Date
November 2024

Targeting Metabolic Vulnerabilities for Treating Medulloblastoma

Grant Information

University of Texas Health Science Center at San Antonio – $50,000

Amount
$50,000.00
Date
November 2024

Targeting RRNA Modification and SNORNA Function, A Novel Concept to Treat Aggressive Medulloblastoma

Grant Information

Children’s National Medical Center – $300,000

Amount
$300,000.00
Date
November 2024

Multilamellar H3K27M RNA aggregates targeting diffuse midline glioma, including diffuse intrinsic pontine glioma.

Grant Information

Children's Hospital Los Angeles – $100,000

Amount
$100,000.00
Date
October 2024

Targeting FOXR2 in Diffuse Midline Gliomas

Grant Information

University Hospital of Navarra - $100,000 USD, €92,637 EUR

Amount
$100,000.00
Date
October 2024

Targeting Diffuse Midline Glioma vulnerabilities as a therapeutic strategy.

Grant Information